XML 18 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash flows from operating activities:    
Net (loss) income $ 864 $ 2,394
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Income from discontinued operations (353) (131)
Net gain from securities transactions (858) (1,852)
Purchases of securities (3,911) (704)
Proceeds from sales of securities 5,538 2,292
Purchases to cover securities sold, not yet purchased (1,390) (692)
Proceeds from securities sold, not yet purchased 949 1,222
Changes in receivables and payables relating to securities transactions (609) (2,702)
Gain on disposition of assets, net (65) (1,969)
Depreciation and amortization 389 406
Impairment 7 76
Deferred taxes (65) (9)
Other, net 39 5
Changes in operating assets and liabilities (554) 340
Net cash used in operating activities from continuing operations (19) (1,324)
Net cash provided by operating activities from discontinued operations 345 410
Net cash provided by (used in) operating activities 326 (914)
Cash flows from investing activities:    
Capital expenditures (276) (333)
Acquisition of businesses, net of cash acquired (13) (105)
Purchase of additional interests in consolidated subsidiaries 0 (349)
Proceeds from disposition of assets 160 1,405
Other, net (20) 14
Net cash (used in) provided by investing activities from continuing operations (149) 632
Net cash used in investing activities from discontinued operations (318) (298)
Net cash (used in) provided by investing activities (467) 334
Cash flows from financing activities:    
Investment segment contributions from non-controlling interests 280 600
Partnership contributions 0 612
Partnership distributions (73) (61)
Proceeds from offering of subsidiary equity 6 0
Dividends and distributions to non-controlling interests in subsidiaries (104) (34)
Proceeds from Holding Company senior unsecured notes 0 1,195
Repayments of Holding Company senior unsecured notes 0 (1,175)
Proceeds from subsidiary borrowings 1,003 843
Repayments of subsidiary borrowings (1,065) (933)
Other, net 6 2
Net cash provided by financing activities from continuing operations 53 1,049
Net cash used in financing activities from discontinued operations (131) (191)
Net cash (used in) provided by financing activities (78) 858
Effect of exchange rate changes on cash and cash equivalents and restricted cash and restricted cash equivalents (1) 2
Add back decrease in cash of assets held for sale 44 232
Net (decrease) increase in cash and cash equivalents and restricted cash and restricted cash equivalents (176) 512
Cash and cash equivalents and restricted cash and restricted cash equivalents, beginning of period 2,030 2,097
Cash and cash equivalents and restricted cash and restricted cash equivalents, end of period 1,854 2,609
Icahn Enterprises Holdings    
Cash flows from operating activities:    
Net (loss) income 865 2,395
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Income from discontinued operations (353) (131)
Net gain from securities transactions (858) (1,852)
Purchases of securities (3,911) (704)
Proceeds from sales of securities 5,538 2,292
Purchases to cover securities sold, not yet purchased (1,390) (692)
Proceeds from securities sold, not yet purchased 949 1,222
Changes in receivables and payables relating to securities transactions (609) (2,702)
Gain on disposition of assets, net (65) (1,969)
Depreciation and amortization 388 405
Impairment 7 76
Deferred taxes (65) (9)
Other, net 39 5
Changes in operating assets and liabilities (554) 340
Net cash used in operating activities from continuing operations (19) (1,324)
Net cash provided by operating activities from discontinued operations 345 410
Net cash provided by (used in) operating activities 326 (914)
Cash flows from investing activities:    
Capital expenditures (276) (333)
Acquisition of businesses, net of cash acquired (13) (105)
Purchase of additional interests in consolidated subsidiaries 0 (349)
Proceeds from disposition of assets 160 1,405
Other, net (20) 14
Net cash (used in) provided by investing activities from continuing operations (149) 632
Net cash used in investing activities from discontinued operations (318) (298)
Net cash (used in) provided by investing activities (467) 334
Cash flows from financing activities:    
Investment segment contributions from non-controlling interests 280 600
Partnership contributions 0 612
Partnership distributions (73) (61)
Proceeds from offering of subsidiary equity 6 0
Dividends and distributions to non-controlling interests in subsidiaries (104) (34)
Proceeds from Holding Company senior unsecured notes 0 1,195
Repayments of Holding Company senior unsecured notes 0 (1,175)
Proceeds from subsidiary borrowings 1,003 843
Repayments of subsidiary borrowings (1,065) (933)
Other, net 6 2
Net cash provided by financing activities from continuing operations 53 1,049
Net cash used in financing activities from discontinued operations (131) (191)
Net cash (used in) provided by financing activities (78) 858
Effect of exchange rate changes on cash and cash equivalents and restricted cash and restricted cash equivalents (1) 2
Add back decrease in cash of assets held for sale 44 232
Net (decrease) increase in cash and cash equivalents and restricted cash and restricted cash equivalents (176) 512
Cash and cash equivalents and restricted cash and restricted cash equivalents, beginning of period 2,030 2,097
Cash and cash equivalents and restricted cash and restricted cash equivalents, end of period $ 1,854 $ 2,609